When a potentially dangerous cell can't be repaired, it must be either stopped or killed. Premature senescence of cancerous cells is one such 'stop' mechanism, in which immune mediators play an unexpected part.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Finkel, T., Serrano, M. & Blasco, M. A. Nature 448, 767–774 (2007).
Kuilman, T. et al. Cell 133, 1019–1031 (2008).
Acosta, J. C. et al. Cell 133, 1006–1018 (2008).
Campisi, J. & d'Adda di Fagagna, F. Nature Rev. Mol. Cell Biol. 8, 729–740 (2007).
Chien, Y. & Lowe, S. W. Cell 132, 339–341 (2008).
Michaloglou, C. et al. Nature 436, 720–724 (2005).
Mason, D. X., Jackson, T. J. & Lin, A. W. Oncogene 23, 9238–9246 (2004).
Schnabl, B., Purbeck, C. A., Choi, Y. H., Hagedorn, C. H. & Brenner, D. Hepatology 37, 653–664 (2003).
Sebastian, T., Malik, R., Thomas, S., Sage, J. & Johnson, P. F. EMBO J. 24, 3301–3312 (2005).
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M. & Green, M. R. Cell 132, 363–374 (2008).
Denoyelle, C. et al. Nature Cell Biol. 8, 1053–1063 (2006).
Rights and permissions
About this article
Cite this article
Soengas, M. Ins and outs of tumour control. Nature 454, 586–587 (2008). https://doi.org/10.1038/454586a
This article is cited by
Hallmarks for senescence in carcinogenesis: novel signaling players